Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma and Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT06902246
What this trial is testing

Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma
University of Miami
Not applicableStudy completedNCT01904942
What this trial is testing

Study of Hepatocellular Carcinoma in Cirrhotic Patients

Who this might be right for
Hepatocellular Carcinoma
Centre Hospitalier Universitaire Dijon 600
Not applicableUnknownNCT04773769
What this trial is testing

Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas

Who this might be right for
Gastric AdenocarcinomaAdenocarcinoma of the Gastroesophageal JunctionHepatocellular Carcinoma+3 more
Auxilio Mutuo Cancer Center 54
Not applicableNot Yet RecruitingNCT07368023
What this trial is testing

A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatocellular Carcinoma Non-resectable
Ningbo Medical Center Lihuili Hospital 300
Testing effectiveness (Phase 2)Looking for participantsNCT07483359
What this trial is testing

Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular Carcinoma (HCC)Portal Vein Tumor Thrombus
First Hospital of China Medical University 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04172779
What this trial is testing

Erlotinib for Hepatocellular Carcinoma Chemoprevention

Who this might be right for
Cirrhosis, LiverAdvanced Liver Fibrosis
University of Texas Southwestern Medical Center 60
Large-scale testing (Phase 3)Looking for participantsNCT06007846
What this trial is testing

A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

Who this might be right for
Hepatocellular CarcinomaCirrhosis
Inova Health Care Services 12
Testing effectiveness (Phase 2)UnknownNCT06375486
What this trial is testing

Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）.

Who this might be right for
Hepatocellular Carcinoma Non-resectableHepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableStudy completedNCT04687280
What this trial is testing

Comparison of Multiphase and Monophasic Arterial Hepatic MRI in the Detection of Arterial Enhancement of CHC Nodules

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Angers 153
Not applicableStudy completedNCT00976898
What this trial is testing

Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma

Who this might be right for
Liver Cancer
Massachusetts General Hospital 83
Early research (Phase 1)Study completedNCT00093444
What this trial is testing

Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors

Who this might be right for
Liver CancerMetastatic Cancer
National Institutes of Health Clinical Center (CC) 30
Testing effectiveness (Phase 2)Ended earlyNCT01101906
What this trial is testing

A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Astellas Pharma Inc 23
Not applicableStudy completedNCT04652947
What this trial is testing

MR Quality + Diagnostic Performance for CHC Diagnosis - Gadoxetic Acid, Gadoteric Acid and P03277 Comparison

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Angers 30
Not applicableStudy completedNCT03301493
What this trial is testing

Genomic Testing and Resulting Medical Decisions

Who this might be right for
Cancer of Unknown OriginCancer RefractoryCancer of Stomach+12 more
Arbeitsgemeinschaft medikamentoese Tumortherapie 1,500
Testing effectiveness (Phase 2)UnknownNCT00471484
What this trial is testing

Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
National Cancer Centre, Singapore 54
Not applicableStudy completedNCT04241887
What this trial is testing

Is Thoracic Paravertebral Block a Better Option Than Conscious Sedation for PRFA of Liver Tumors

Who this might be right for
Liver Tumor
University of Warmia and Mazury 30
Not applicableStudy completedNCT05739110
What this trial is testing

HCC Staging Modified by Tumor Micronecrosis

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 1,100
Early research (Phase 1)Looking for participantsNCT07116486
What this trial is testing

A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
M.D. Anderson Cancer Center 60
Early research (Phase 1)Study completedNCT02387307
What this trial is testing

RSIFN-co in Subjects With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellMelanoma+2 more
Sichuan Huiyang Life Science and Technology Corporation 42
Testing effectiveness (Phase 2)Study completedNCT03890731
What this trial is testing

A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed

Who this might be right for
Solid Cancer
Bayer 6
Next Page